Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ME3 |
| Upstream (Parents) |
|---|
| (<<) PRSS8 → ME3 |
| (<<) SLC7A6 → ME3 |
| (<<) LY75 → ME3 |
| (<<) SGPP1 → ME3 |
| Downstream (Children) |
|---|
| ME3 → ST8SIA1 (>>) |
| ME3 → LPAR3 (>>) |
| ME3 → COL2A1 (>>) |
| ME3 → KIT (>>) |
| ME3 → VDAC1P8///LOC100288558///ADAT2///PEX3///FUCA2 (>>) |
| ME3 → HOXA5 (>>) |
| ME3 → ARHGAP4 (>>) |
| ME3 → CYP2W1 (>>) |
| ME3 → FSD1 (>>) |
| ME3 → SPOCK2 (>>) |
| ME3 → LOC654342 (>>) |
| ME3 → MARK4 (>>) |
| ME3 → AHSP (>>) |
| ME3 → SLCO3A1 (>>) |
